Evaluation of Drug Prescriptions on Hospital Admission in Older Trauma Patients Using the Fit FOR The Aged (FORTA) Rules

Overview

Journal Z Gerontol Geriatr

Publisher Springer

Specialty Geriatrics

Date 2024 Sep 26

PMID 39327276

Authors

Carla Stenmanns

Henriette-Sophie Moellmann

Martin Wehling

Helmut Frohnhofen

Affiliations

Soon will be listed here.

Abstract

Background: Orthogeriatric comanagement of older patients with hip fractures has been proven to provide significant benefits concerning functional status, readmissions, nursing home placement, in-hospital complications and mortality. Medication management in older individuals is a cornerstone in orthogeriatric comanagement. The aim of the study was to analyze the extent of overprescription and undertreatment in older trauma patients.

Methods: Personal and medical data of consecutively admitted older trauma patients were analyzed. Evaluation of medication was conducted according to the Fit fOR The Aged (FORTA) criteria. Data were retrieved from an ongoing observational study on the incidence of delirium in surgical patients.

Results: A total of 492 patients were enrolled. There were 374 cases of overprescription and 575 cases of undertreatment. Only 78 (16%) patients had neither overprescription nor undertreatment on admission. Overprescription and undertreatment were most prevalent in cardiovascular disease. Undertreatment was most prevalent concerning osteoporosis. The number of prescribed drugs correlated with the Charlson Comorbidity Index (r = 0.478, p < 0.001), age (r = 0.122; p < 0.01), anticholinergic burden (r = 0.528, p < 0.001), FORTA score (r = 0.352, p < 0.001), and overtreatment (r = 0.492, p < 0.001), but not with undertreatment. Undertreatment also correlated with age (r = 0.172, p < 0.001) and overtreatment (r = 0.364, p < 0.01). The FORTA score correlated significantly with age (r = 0.159, p < 0.001), anticholinergic burden (ACB) score (r = 0.496, p < 0.001), Katz index (r = -0.119, p < 0.01), IADL score (r = -0.243, p < 0.001), and clinical frailty scale (CFS, r = 0.23, p < 0.001).

Conclusion: The high numbers of overprescription and undertreatment in older trauma patients underlines the need for orthogeriatric comanagement. Besides the evaluation of multimorbidity and geriatric problems, drug management is a core topic. Future studies should investigate the impact of medication management on outcome parameters such as quality of life, functional status, and mortality. A benefit can be expected.

References

Aggarwal P, Woolford S, Patel H . Multi-Morbidity and Polypharmacy in Older People: Challenges and Opportunities for Clinical Practice. Geriatrics (Basel). 2020; 5(4). PMC: 7709573. DOI: 10.3390/geriatrics5040085. View

Braithwaite E, Todd O, Atkin A, Hulatt R, Tadrous R, Alldred D . Interventions for reducing anticholinergic medication burden in older adults-a systematic review and meta-analysis. Age Ageing. 2023; 52(9). PMC: 10517713. DOI: 10.1093/ageing/afad176. View

Coupland C, Hill T, Dening T, Morriss R, Moore M, Hippisley-Cox J . Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study. JAMA Intern Med. 2019; 179(8):1084-1093. PMC: 6593623. DOI: 10.1001/jamainternmed.2019.0677. View

Forch S, Kretschmer R, Haufe T, Plath J, Mayr E . Orthogeriatric Combined Management of Elderly Patients With Proximal Femoral Fracture: Results of a 1-Year Follow-Up. Geriatr Orthop Surg Rehabil. 2017; 8(2):109-114. PMC: 5431412. DOI: 10.1177/2151458517698536. View

Gosch M, Hoffmann-Weltin Y, Roth T, Blauth M, Nicholas J, Kammerlander C . Orthogeriatric co-management improves the outcome of long-term care residents with fragility fractures. Arch Orthop Trauma Surg. 2016; 136(10):1403-9. PMC: 5025484. DOI: 10.1007/s00402-016-2543-4. View

Green A, Reifler L, Bayliss E, Weffald L, Boyd C . Drugs Contributing to Anticholinergic Burden and Risk of Fall or Fall-Related Injury among Older Adults with Mild Cognitive Impairment, Dementia and Multiple Chronic Conditions: A Retrospective Cohort Study. Drugs Aging. 2019; 36(3):289-297. PMC: 6386184. DOI: 10.1007/s40266-018-00630-z. View

Harstedt M, Rogmark C, Sutton R, Melander O, Fedorowski A . Polypharmacy and adverse outcomes after hip fracture surgery. J Orthop Surg Res. 2016; 11(1):151. PMC: 5122200. DOI: 10.1186/s13018-016-0486-7. View

Huh Y, Kim Y, Choi J, Lee J, Jung H, Shin C . Comparison of anticholinergic burden with chronic polypharmacy on functional decline and mortality in Korean older people: a retrospective nationwide cohort study. BMC Geriatr. 2024; 24(1):90. PMC: 10807110. DOI: 10.1186/s12877-024-04692-0. View

Jain B, Bajaj S, Amen T, Dee E, Palakodeti S . Orthogeriatric co-management care models: The need for integrated practice units. Lancet Reg Health West Pac. 2022; 21:100416. PMC: 8928085. DOI: 10.1016/j.lanwpc.2022.100416. View

10.

Keller M, Qureshi N, Mays A, Sarkisian C, Pevnick J . Cumulative Update of a Systematic Overview Evaluating Interventions Addressing Polypharmacy. JAMA Netw Open. 2024; 7(1):e2350963. PMC: 10782233. DOI: 10.1001/jamanetworkopen.2023.50963. View

11.

Khezrian M, McNeil C, Murray A, Myint P . An overview of prevalence, determinants and health outcomes of polypharmacy. Ther Adv Drug Saf. 2020; 11:2042098620933741. PMC: 7294476. DOI: 10.1177/2042098620933741. View

12.

Luegering A, Frohnhofen H, Langner R, Wilm S, Doeppner T, Hermann D . Problems in Medication Self-Management by Elderly Patients. Dtsch Arztebl Int. 2023; 120(33-34):559-560. PMC: 10546887. DOI: 10.3238/arztebl.m2023.0144. View

13.

Michalek C, Wehling M, Schlitzer J, Frohnhofen H . Effects of "Fit fOR The Aged" (FORTA) on pharmacotherapy and clinical endpoints--a pilot randomized controlled study. Eur J Clin Pharmacol. 2014; 70(10):1261-7. DOI: 10.1007/s00228-014-1731-9. View

14.

Nicholson K, Liu W, Fitzpatrick D, Hardacre K, Roberts S, Salerno J . Prevalence of multimorbidity and polypharmacy among adults and older adults: a systematic review. Lancet Healthy Longev. 2024; 5(4):e287-e296. DOI: 10.1016/S2666-7568(24)00007-2. View

15.

OMahony D, OSullivan D, Byrne S, OConnor M, Ryan C, Gallagher P . STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2014; 44(2):213-8. PMC: 4339726. DOI: 10.1093/ageing/afu145. View

16.

ONeil H, Todd A, Pearce M, Husband A . What are the consequences of over and undertreatment of type 2 diabetes mellitus in a frail population? A systematic review. Endocrinol Diabetes Metab. 2024; 7(2):e00470. PMC: 10897870. DOI: 10.1002/edm2.470. View

17.

Pazan F, Wehling M, Weiss C, Frohnhofen H . Medication optimization according to the Fit fOR The Aged (FORTA) rules improves functional status in patients hospitalized for geriatric rehabilitation. Eur Geriatr Med. 2023; 14(3):477-483. PMC: 10261185. DOI: 10.1007/s41999-023-00779-w. View

18.

Pulok M, Theou O, van der Valk A, Rockwood K . The role of illness acuity on the association between frailty and mortality in emergency department patients referred to internal medicine. Age Ageing. 2020; 49(6):1071-1079. PMC: 7583513. DOI: 10.1093/ageing/afaa089. View

19.

Rudolph J, Salow M, Angelini M, McGlinchey R . The anticholinergic risk scale and anticholinergic adverse effects in older persons. Arch Intern Med. 2008; 168(5):508-13. DOI: 10.1001/archinternmed.2007.106. View

20.

Wehling M, Burkhardt H, Kuhn-Thiel A, Pazan F, Throm C, Weiss C . VALFORTA: a randomised trial to validate the FORTA (Fit fOR The Aged) classification. Age Ageing. 2016; 45(2):262-7. DOI: 10.1093/ageing/afv200. View